Dr. Mauer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Center for Advanced Care
900 West Nelson St
Chicago, IL 60657Phone+1 773-296-7089Fax+1 773-296-7311
Summary
- Dr. Ann Mauer is an oncologist in Chicago, IL and is affiliated with Advocate Illinois Masonic Medical Center. She received her medical degree from Loyola University Chicago Stritch School of Medicine and has been in practice 25 years. She specializes in breast cancer, cancer genetics/cancer risk assessment, and hematologic oncology and is experienced in breast cancer, lung cancer, and general medical oncology. She has more than 100 publications and over 500 citings.
Education & Training
- University of ChicagoFellowship, Hematology and Medical Oncology, 1995 - 1998
- University of ChicagoResidency, Internal Medicine, 1992 - 1995
- Loyola University Chicago Stritch School of MedicineClass of 1992
Certifications & Licensure
- IL State Medical License 1992 - 2026
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- Paclitaxel and Oxaliplatin in Treating Patients With Recurrent or Advanced Non-small Cell Lung Cancer Start of enrollment: 1999 Nov 01
- Oxaliplatin Combined With Fluorouracil and Leucovorin in Treating Patients With Recurrent or Metastatic Cancer of the Esophagus or Stomach Start of enrollment: 2000 Feb 01
- Bryostatin 1 Plus Paclitaxel in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell Lung Cancer Start of enrollment: 2000 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- 174 citationsPhase II Trial of Gefitinib 250 mg Daily in Patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and NeckEzra E.W. Cohen, Madeleine A. Kane, Marcy A. List, Bruce Brockstein, Bhoomi Mehrotra
Clinical Cancer Research. 2005-12-01 - 16 citationsA phase II trial of 9-aminocaptothecin (9-AC) as a 120-h infusion in patients with non-small cell lung cancer.Everett E. Vokes, Gary S. Gordon, Charles M. Rudin, Ann M. Mauer, S. Watson
Investigational New Drugs. 2001-01-01 - 151 citationsEicosanoid Modulation in Advanced Lung Cancer: Cyclooxygenase-2 Expression Is a Positive Predictive Factor for Celecoxib + Chemotherapy--Cancer and Leukemia Group B Tr...Martin J. Edelman, Dee Watson, Xiaofei Wang, Carl Morrison, Robert A. Kratzke
Journal of Clinical Oncology. 2008-02-20
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: